Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Can Activation of NRF2 Be a Strategy against COVID-19?
Antonio Cuadrado, Marta Pajares, Cristina Benito, et al.
Trends in Pharmacological Sciences (2020) Vol. 41, Iss. 9, pp. 598-610
Open Access | Times Cited: 216

Showing 26-50 of 216 citing articles:

Anti-Viral Potential and Modulation of Nrf2 by Curcumin: Pharmacological Implications
Mahdie Rahban, Mehran Habibi-Rezaei, Mansooreh Mazaheri, et al.
Antioxidants (2020) Vol. 9, Iss. 12, pp. 1228-1228
Open Access | Times Cited: 62
Insights on the mechanisms of action of ozone in the medical therapy against COVID-19
Salvatore Chirumbolo, Luigi Valdenassi, Vincenzo Simonetti, et al.
International Immunopharmacology (2021) Vol. 96, pp. 107777-107777
Open Access | Times Cited: 50
Anti-Inflammatory and Anticancer Properties of Birch Bark-Derived Betulin: Recent Developments
Hardeep Singh Tuli, Katrin Sak, Dhruv Gupta, et al.
Plants (2021) Vol. 10, Iss. 12, pp. 2663-2663
Open Access | Times Cited: 50
SARS-CoV-2 Infection and Oral Health: Therapeutic Opportunities and Challenges
Christopher J. Coke, Brandon Davison, Niariah Fields, et al.
Journal of Clinical Medicine (2021) Vol. 10, Iss. 1, pp. 156-156
Open Access | Times Cited: 45
GDF15: an emerging modulator of immunity and a strategy in COVID-19 in association with iron metabolism
Luc Rochette, Marianne Zeller, Yves Cottin, et al.
Trends in Endocrinology and Metabolism (2021) Vol. 32, Iss. 11, pp. 875-889
Open Access | Times Cited: 43
Bardoxolone and bardoxolone methyl, two Nrf2 activators in clinical trials, inhibit SARS-CoV-2 replication and its 3C-like protease
Qi Sun, Fei Ye, Hao Liang, et al.
Signal Transduction and Targeted Therapy (2021) Vol. 6, Iss. 1
Open Access | Times Cited: 42
Potential Interplay between Nrf2, TRPA1, and TRPV1 in Nutrients for the Control of COVID-19
Jean Bousquet, Heather J. Zar, Torsten Zuberbier, et al.
International Archives of Allergy and Immunology (2021) Vol. 182, Iss. 4, pp. 324-338
Open Access | Times Cited: 41
The age-dependent decline of the extracellular thiol-disulfide balance and its role in SARS-CoV-2 infection
Daniela Giustarini, Annalisa Santucci, Desirée Bartolini, et al.
Redox Biology (2021) Vol. 41, pp. 101902-101902
Open Access | Times Cited: 41
Glutathione deficiency in the pathogenesis of SARS-CoV-2 infection and its effects upon the host immune response in severe COVID-19 disease
Carlos A. Labarrere, Ghassan S. Kassab
Frontiers in Microbiology (2022) Vol. 13
Open Access | Times Cited: 33
Potential role of lipoxin in the management of COVID-19: a narrative review
Gaber El‐Saber Batiha, Ali I. Al‐Gareeb, Engy Elekhnawy, et al.
Inflammopharmacology (2022) Vol. 30, Iss. 6, pp. 1993-2001
Open Access | Times Cited: 32
Mechanistic Understanding of Lung Inflammation: Recent Advances and Emerging Techniques
Chrysi Keskinidou, Alice G. Vassiliou, Ioanna Dimopoulou, et al.
Journal of Inflammation Research (2022) Vol. Volume 15, pp. 3501-3546
Open Access | Times Cited: 28
Molecular Mechanisms Related to Responses to Oxidative Stress and Antioxidative Therapies in COVID-19: A Systematic Review
Evangelia Eirini Tsermpini, Una Glamočlija, Fulden Ulucan‐Karnak, et al.
Antioxidants (2022) Vol. 11, Iss. 8, pp. 1609-1609
Open Access | Times Cited: 27
Structural and biochemical characterization establishes a detailed understanding of KEAP1-CUL3 complex assembly
R.J. Adamson, N. Connor Payne, Sergio G. Bartual, et al.
Free Radical Biology and Medicine (2023) Vol. 204, pp. 215-225
Open Access | Times Cited: 17
Modulation of NRF2: Biological Dualism in Cancer, Targets and Possible Therapeutic Applications
M. Gallorini, Simone Carradori, Emiliano Panieri, et al.
Antioxidants and Redox Signaling (2023) Vol. 40, Iss. 10-12, pp. 636-662
Closed Access | Times Cited: 15
Therapeutic implications of quercetin and its derived-products in COVID-19 protection and prophylactic
Wan‐Yi Ho, Zi-han Shen, Yijing Chen, et al.
Heliyon (2024) Vol. 10, Iss. 9, pp. e30080-e30080
Open Access | Times Cited: 5
NRF2-mediated regulation of lipid pathways in viral infection
Khursheed Muzammil, Zahraa Sabah Ghnim, Ibrahim Saeed Gataa, et al.
Molecular Aspects of Medicine (2024) Vol. 97, pp. 101279-101279
Closed Access | Times Cited: 5
COVID-19 Humic/Fulvic Acid Plus Epigallocatechin Gallate Treatment: A Retrospective Chart Review
Richard Williams
Cureus (2025)
Open Access
Protective Effects of Sulforaphane Preventing Inflammation and Oxidative Stress to Enhance Metabolic Health: A Narrative Review
Inês Alves, Edilene Maria Queiroz Araújo, Louise T. Dalgaard, et al.
Nutrients (2025) Vol. 17, Iss. 3, pp. 428-428
Open Access
Bronchoalveolar lavage single-cell transcriptomics reveals immune dysregulations driving COVID-19 severity
Njinju Asaba Clinton, Razieh Bitazar, Patrick Labonté, et al.
PLoS ONE (2025) Vol. 20, Iss. 2, pp. e0309880-e0309880
Open Access
Health position paper and redox perspectives – Bench to Bedside Transition for Pharmacological Regulation of NRF2 in Noncommunicable Diseases
Antonio Cuadrado, Eduardo Cazalla, Anders Bach, et al.
Redox Biology (2025), pp. 103569-103569
Open Access
Nrf2 activation putatively mediates clinical benefits of low-dose radiotherapy in COVID-19 pneumonia and acute respiratory distress syndrome (ARDS): Novel mechanistic considerations
Edward J. Calabrese, Walter J. Kozumbo, Rachna Kapoor, et al.
Radiotherapy and Oncology (2021) Vol. 160, pp. 125-131
Open Access | Times Cited: 38
COVID-19: A Redox Disease—What a Stress Pandemic Can Teach Us About Resilience and What We May Learn from the Reactive Species Interactome About Its Treatment
Andrew F. Cumpstey, Anna D. Clark, Jérôme Santolini, et al.
Antioxidants and Redox Signaling (2021) Vol. 35, Iss. 14, pp. 1226-1268
Open Access | Times Cited: 38
Therapeutic Potential of EGCG, a Green Tea Polyphenol, for Treatment of Coronavirus Diseases
Junsoo Park, Rackhyun Park, Minsu Jang, et al.
Life (2021) Vol. 11, Iss. 3, pp. 197-197
Open Access | Times Cited: 37
Therapeutic potential of chelerythrine as a multi-purpose adjuvant for the treatment of COVID-19
Mehdi Valipour, Afshin Zarghi, Mohammad Ali Ebrahimzadeh, et al.
Cell Cycle (2021) Vol. 20, Iss. 22, pp. 2321-2336
Open Access | Times Cited: 35
Inhibitory effects of sulforaphane on NLRP3 inflammasome activation
Cagla Kiser, Ceren Perihan Gonul, Melis Olcum, et al.
Molecular Immunology (2021) Vol. 140, pp. 175-185
Closed Access | Times Cited: 35

Scroll to top